This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases.

The authors have nothing to disclose.

Quantificação absoluta de proteína é essencial para uma gama muito diversificada de aplicações biomédicas tais como validação de biomarcadores e modelagem via de transdução de sinal. Recentemente, proteômica direcionados utilizando LC-SRM beneficiou de melhorias para várias tecnologias, incluindo a preparação de péptidos padrão, HPLC, qq-MS, e análise de dados LC-SRM. Por conseguinte, tornou-se uma alternativa poderosa para imunoensaios. Imunoensaios podem ser extremamente sensíveis e de alto rendimen...

Experimentos de proteômica que usam a espectrometria de massa (MS) pode ser projetado para usar um não-alvo (espingarda) ou métodos direcionados. Proteómica descoberta baseia-se na espingarda geralmente de baixo para cima MS, usando um modo de aquisição dependente dos dados tradicional, ou utilizando uma das técnicas independentes de dados desenvolvidas recentemente (por exemplo, MS E, SWATH) 1,2. Proteómica espingarda é uma ferramenta poderosa para a identificação de alto rendimento péptido e quantificação relativa, mas é geralmente inadequada para a quantificação absoluta ou para o direccionamento pequenos conjuntos, definidos ~ (RTE) de proteínas. O método MS mais frequentemente usado para proteômica alvejados é selecionado monitoramento de reação (SRM) por causa de sua alta sensibilidade, velocidade e alcance dinâmico 3-5. Alternativas a SRM incluem monitoramento de reação paralela, que tira proveito de alta resolução, completa varredura MS 6. SRM é geralmente realizada utilizando um fluxo de rever nano-sed cromatografia em fase líquida de alta eficiência (nano-RP-LC) acoplado a um instrumento de ionização por electropulverização de nano-(nano-ESI) ligado a fonte de iões de um espectrómetro de massa triplo quadrupolo (QQQ-MS). Numa experiência típica, as proteínas da amostra são proteoliticamente digeridos, e os peptídeos resultantes foram separados cromatograficamente, dessorvido, e ionizado. Os iões resultantes são precursoras m / z filtrada por o primeiro quadrupolo (Q1) e fragmentada no segundo quadrupolo (Q2) por colidir com um gás de colisão. Os iões resultantes são fragmento m / no terceiro quadrupolo (Q3) e quantificada por um dínodo filtrou-z. Cada par de iões fragmento precursor e é referido como uma transição, e cada transição é monitorizado por um período determinado de tempo (tempo de espera, tipicamente 2-50 ms). Durante LC-SRM, os ciclos QQQ-MS por meio de uma lista pré-definida de transição (o ciclo de serviço é tipicamente ≤3 seg), e um cromatograma de cada transição é produzido. Strateg alternativas para a quantificação de proteínas normalmente utilizam imunoensaios tais como borrões ponto, manchas de Western, ELISAs, microarrays de anticorpos, microarrays de proteínas de fase reversa, imunoensaios microfluídicos, ELISAs digitais e imunoensaios à base de microesferas 7. Os melhores imunoensaios podem ser significativamente mais sensíveis do que os LC-SRM, e o manuseamento das amostras de imunoensaios podem ser significativamente mais elevada do que a da LC-5 SRM. No entanto, imunoensaios em desenvolvimento pode ser caro e / ou demorado, e os ensaios resultantes podem estar vulneráveis ​​a reactividade cruzada e / ou interferências, incompatível com células / tecido de lise / métodos de homogeneização, e / ou não passíveis de multiplexagem 5,8. Algumas dessas questões podem ser abordadas por acoplamento técnicas anticorpo-e baseado no MS. Por exemplo, as proteínas alvo podem ser enriquecidas utilizando imunoprecipitação prévia à proteólise e LC-SRM 9-12. Alternativamente, a técnica emprega SISCAPA imunoprecipitação subsequente à proteólise no leve peptídeol 13,14. Além immunoenrichment estratégias, imunodepleção de proteínas de alta abundância pode ser empregue para aumentar a sensibilidade de LC-SRM, reduzindo a interferência por coeluting analitos 15,16. Quantificação de proteína baseada em MS pode ser dividido em quantificação relativa e absoluta, e também para rotulagem isótopo estável e livre de marcador (por exemplo, a etiquetagem metabólica, marcação química, e pesada da proteína marcada com padrões internos e peptídicos). Técnicas livre de marcador pode ser útil para a quantificação relativa de proteína, mas não são adequados para a quantificação exacta absoluta. Por comparação, técnicas de marcação já reduzida de erro associado com a preparação da amostra e da variância MS, e são muitas vezes utilizados para a quantificação relativa de proteína 17. Por exemplo, os padrões de isótopos estáveis ​​proteoma marcado (SILAP) preparado utilizando uma linha de células humanas de cultura permitiu a quantificação relativa de biomarcadores potenciais através de LC-SRM de soro humano 18. Accurate quantificação absoluta de proteína por MS requer que as normas internas purificada, quantificado, proteínas isotopicamente marcada ou peptídeo ser cravado-em amostras biológicas antes de MS. A incorporação de padrões internos marcados com isótopos pesados ​​em um fluxo de trabalho LC-SRM permite a quantificação absoluta de que foi mostrado ser altamente reprodutível e transferível entre laboratórios 16,19. Rotulados padrões internos de isótopos estáveis ​​para a quantificação absoluta de proteína por MS incluem padrões de peptídeos preparados usando a síntese em fase sólida 20, proteínas compostas de padrões de peptídeos protease clivável concatenadas 21, e padrões de proteína de comprimento total 22. Alvo modificação covalente de proteínas e preparação de amostras incompletas (por exemplo, a lise da amostra incompleta e homogeneização, e solubilização de proteínas incompletas, a desnaturação, a alquilação, e a proteólise) pode prejudicar a quantificação precisa. P Internonormas rotein são os menos susceptíveis de serem afectadas pela maioria desses problemas potenciais, mas eles geralmente são os mais difíceis de preparar. Uma alternativa é a de analisar cada proteína alvo utilizando vários padrões peptídicos internos que são concebidos para incluir os resíduos de flanqueamento nativos amino e carboxi-terminais. Independentemente de qual o tipo de padrão interno é utilizado, ele deve ser cravado-os em amostras biológicas, o mais a altura durante a preparação da amostra quanto possível. Além disso, técnicas de preparação de amostras múltiplas (por exemplo, as diferentes condições de desnaturação) deve ser testado. O uso de várias técnicas experimentais ortogonais (de validação cruzada experimental) é uma estratégia viável para a superação de mais quantificação potencial desafia 23-25. LC-SRM quantificação de proteínas é uma técnica altamente flexível, que foi utilizado numa ampla variedade de aplicações. Notavelmente, tem sido utilizada para estudar peptídicos e proteicos biomarcadores dentroamostras clínicas, tais como soro, biópsias, e punção aspirativa por agulha fina 5. LC-SRM também tem sido utilizado para medir a estequiometria de complexos de proteínas 5,26, para detectar neurotoxinas botulínicas 27, para quantificar dinâmica de fosforilação de proteína dentro de vias de sinalização 5, e para quantificar as alterações na conformação da proteína 28. Nosso laboratório está usando LC-SRM para quantificar as proteínas sinalizadoras que medeiam a quimiotaxia de macrófagos para apoiar o desenvolvimento de simulações via quimiotaxia. O esquema geral do protocolo (Figura 1) começa com o ranking dos peptídeos alvo provisórias. Subsequentemente, padrões externos de péptidos em bruto são sintetizados e utilizados para desenvolver testes de LC-SRM para análises qualitativas de amostras biológicas. Se o péptido alvo biológico derivado de amostra é detectada, padrões peptídicos internos pesados ​​marcado purificados são preparados por LC-quantitativa SRM. Este protocolo pode ser utilizado para accurately quantificar proteínas a partir de uma grande variedade de amostras biológicas, e para apoiar as investigações de uma grande variedade de alvos de proteína.

<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td>Acetonitrile (ACN), LC-MS grade</td>
			<td>Fisher</td>
			<td>A955-1</td>
			<td></td>
		</tr>
		<tr>
			<td>BCA (bicinchoninic acid) protein assay kit</td>
			<td>Fisher</td>
			<td>23235</td>
			<td></td>
		</tr>
		<tr>
			<td>Beads for bead beating, zirconia-silica, 0.1mm</td>
			<td>BioSpec Products</td>
			<td>11079101z</td>
			<td></td>
		</tr>
		<tr>
			<td>Bestatin hydrochloride</td>
			<td>Sigma</td>
			<td>B8385-10MG</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell culture DMEM (with glucose, without L-glutamine)</td>
			<td>Lonza</td>
			<td>12-614F</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell culture EDTA, 500mM, pH8</td>
			<td>Gibco</td>
			<td>15575</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell culture fetal bovine serum (FBS)</td>
			<td>Atlanta Biologicals</td>
			<td>S11550</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell culture L-glutamine</td>
			<td>Sigma</td>
			<td>G8540-25G</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell culture phosphate buffered saline (PBS) pH 7.4</td>
			<td>Gibco</td>
			<td>10010-049</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell culture Trypan Blue viability stain, 0.4% w/v</td>
			<td>Lonza</td>
			<td>17-942E</td>
			<td></td>
		</tr>
		<tr>
			<td>Cellometer Auto T4 cell counter</td>
			<td>Nexcelom Bioscience</td>
			<td>Cellometer Auto T4</td>
			<td></td>
		</tr>
		<tr>
			<td>Cellometer Auto T4 disposable counting chambers</td>
			<td>Nexcelom Bioscience</td>
			<td>CHT4-SD100-014</td>
			<td></td>
		</tr>
		<tr>
			<td>Dithiothreitol (DTT)</td>
			<td>Sigma</td>
			<td>D5545-5G</td>
			<td></td>
		</tr>
		<tr>
			<td>Formic acid, LC-MS grade, ampules</td>
			<td>Fisher</td>
			<td>A117-10X1AMP</td>
			<td></td>
		</tr>
		<tr>
			<td>Hemocytometer, Neubauer-improved, 0.1mm deep</td>
			<td>Marienfeld-Superior</td>
			<td>0640030</td>
			<td></td>
		</tr>
		<tr>
			<td>HEPES, 1M, pH 7.2</td>
			<td>Mediatech</td>
			<td>25-060-CI</td>
			<td></td>
		</tr>
		<tr>
			<td>Hydrochloric acid, 37% w/w</td>
			<td>VWR</td>
			<td>BDH3028-2.5LG</td>
			<td></td>
		</tr>
		<tr>
			<td>Iodoacetamide</td>
			<td>Sigma</td>
			<td>I1149-5G</td>
			<td></td>
		</tr>
		<tr>
			<td>Laser Based Micropipette Puller</td>
			<td>Sutter Instrument Co.</td>
			<td>P-2000</td>
			<td></td>
		</tr>
		<tr>
			<td>LC Magic C18AQ, 5&#181;m, 200&#8491;, loose media</td>
			<td>Michrom Bioresources</td>
			<td>PM5/61200/00</td>
			<td></td>
		</tr>
		<tr>
			<td>LC Halo ES-C18, 2.7&#181;m, 160&#8491;, loose media</td>
			<td>Michrom Bioresources</td>
			<td>PM3/93100/00</td>
			<td></td>
		</tr>
		<tr>
			<td>LC coated silica capillary, 50&#181;m id</td>
			<td>Polymicro Technologies</td>
			<td>1068150017</td>
			<td></td>
		</tr>
		<tr>
			<td>LC vial, autosampler, 12x32mm polypropylene</td>
			<td>SUN SRI</td>
			<td>200-268</td>
			<td></td>
		</tr>
		<tr>
			<td>LC vial screw cap, autosampler, pre-slit PTFE/silicone</td>
			<td>SUN SRI</td>
			<td>500-061</td>
			<td></td>
		</tr>
		<tr>
			<td>Luciferase, from Photinus pyralis</td>
			<td>Sigma</td>
			<td>L9506-1MG</td>
			<td></td>
		</tr>
		<tr>
			<td>Pepstatin A</td>
			<td>EMD Millipore</td>
			<td>516481-25MG</td>
			<td></td>
		</tr>
		<tr>
			<td>pH strips colorpHast (pH 0.0-6.0)</td>
			<td>EMD Chemicals</td>
			<td>9586-1</td>
			<td></td>
		</tr>
		<tr>
			<td>PhosStop phosphatase inhibitor cocktail</td>
			<td>Roche</td>
			<td>04906837001</td>
			<td></td>
		</tr>
		<tr>
			<td>RapiGest SF</td>
			<td>Waters</td>
			<td>186001861</td>
			<td></td>
		</tr>
		<tr>
			<td>Sep-Pak SPE, C18 1ml 100mg cartridge</td>
			<td>Waters</td>
			<td>WAT023590</td>
			<td></td>
		</tr>
		<tr>
			<td>Sep-Pak SPE, extraction manifold, 20 position</td>
			<td>Waters</td>
			<td>WAT200609</td>
			<td></td>
		</tr>
		<tr>
			<td>Sep-Pak SPE, flat-surfaced rubber bulb</td>
			<td>Fisher</td>
			<td>03-448-25</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium hydroxide (NaOH)</td>
			<td>Fisher</td>
			<td>S318-500</td>
			<td></td>
		</tr>
		<tr>
			<td>SpeedVac vacuum concentrator</td>
			<td>Fisher</td>
			<td>SPD111V</td>
			<td></td>
		</tr>
		<tr>
			<td>Trifluoroacetic acid (TFA), LC-MS grade</td>
			<td>Fisher</td>
			<td>A116-50</td>
			<td></td>
		</tr>
		<tr>
			<td>Trypsin, sequencing grade, modified</td>
			<td>Promega</td>
			<td>V5113</td>
			<td></td>
		</tr>
		<tr>
			<td>Tube decapper for Micronic tubes</td>
			<td>USA Scientific</td>
			<td>1765-4000</td>
			<td></td>
		</tr>
		<tr>
			<td>Tubes, 2ml microcentrifuge, o-ring screw-cap, sterile</td>
			<td>Sarstedt</td>
			<td>72.694.006</td>
			<td></td>
		</tr>
		<tr>
			<td>Urea</td>
			<td>Sigma</td>
			<td>U0631-500g</td>
			<td></td>
		</tr>
		<tr>
			<td>Water, LC-MS grade</td>
			<td>Fisher</td>
			<td>W6-1</td>
			<td></td>
		</tr>
	</tbody>
</table>

selected reaction monitoring mass spectrometry for absolute protein quantification

Absolute quantification of target proteins within complex biological samples is critical to a wide range of research and clinical applications. This protocol provides step-by-step instructions for the development and application of quantitative assays using selected reaction monitoring (SRM) mass spectrometry (MS). First, likely quantotypic target peptides are identified based on numerous criteria. This includes identifying proteotypic peptides, avoiding sites of posttranslational modification, and analyzing the uniqueness of the target peptide to the target protein. Next, crude external peptide standards are synthesized and used to develop SRM assays, and the resulting assays are used to perform qualitative analyses of the biological samples. Finally, purified, quantified, heavy isotope labeled internal peptide standards are prepared and used to perform isotope dilution series SRM assays. Analysis of all of the resulting MS data is presented. This protocol was used to accurately assay the absolute abundance of proteins of the chemotaxis signaling pathway within RAW 264.7 cells (a mouse monocyte/macrophage cell line). The quantification of Gi2 (a heterotrimeric G-protein &#945;-subunit) is described in detail.

O desenvolvimento de modelos computacionais preditivos de vias de transdução de sinal é um dos objectivos fundamentais da Biologia de Sistemas 53. Infelizmente, mesmo para as vias de sinalização que têm sido estudados extensivamente e têm um elevado significado clínico, que ainda não é geralmente possível prever o comportamento quantitativamente via em resposta a perturbações (por exemplo, isto é verdadeiro para a MAPK / ERK 54). Recentemente, uma investigação empregada pro...

Watch this Scientific Journal Video about Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification at JoVE.com

Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification

This protocol describes how to perform absolute quantification assays of target proteins within complex biological samples using selected reaction monitoring. It was used to accurately quantify proteins of the mouse macrophage chemotaxis signaling pathway. Target peptide selection, assay development, and qualitative and quantitative assays are described in detail.

Reação selecionada Monitoramento Espectrometria de Massa para Absolute Quantificação de Proteína

Absolute quantification of target proteins within complex biological samples is critical to a wide range of research and clinical applications. This ...

selected-reaction-monitoring-mass-spectrometry-for-absolute-protein

Research

JoVE Journal

Biology

16.9K visualizações.  National Institutes of Health. This protocol describes how to perform absolute quantification assays of target proteins within complex biological samples using selected reaction monitoring. It was used to accurately quantify proteins of the mouse macrophage chemotaxis signaling pathway. Target peptide selection, assay development, and qualitative and quantitative assays are described in detail.

Vídeo: Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification

MALDI Sample Preparation: the Ultra Thin Layer Method

This video demonstrates the preparation of an ultra-thin matrix/analyte layer for analyzing peptides and proteins by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS) 1,2. The ultra-thin layer method involves the production of a substrate layer of matrix crystals (alpha-cyano-4-hydroxycinnamic acid) on the sample plate, which serves as a seeding ground for subsequent crystallization of a matrix/analyte mixture. Advantages of the ultra-thin layer method over other sample deposition approaches (e.g. dried droplet) are that it provides (i) greater tolerance to impurities such as salts and detergents, (ii) better resolution, and (iii) higher spatial uniformity. This method is especially useful for the accurate mass determination of proteins. The protocol was initially developed and optimized for the analysis of membrane proteins and used to successfully analyze ion channels, metabolite transporters, and receptors, containing between 2 and 12 transmembrane domains 2. Since the original publication, it has also shown to be equally useful for the analysis of soluble proteins. Indeed, we have used it for a large number of proteins having a wide range of properties, including those with molecular masses as high as 380 kDa 3. It is currently our method of choice for the molecular mass analysis of all proteins. The described procedure consistently produces high-quality spectra, and it is sensitive, robust, and easy to implement.

This video demonstrates the preparation of an ultra-thin matrix/analyte layer for analyzing peptides and proteins by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS).

MALDI preparação da amostra: o método de Camada Ultra Thin

This video demonstrates the preparation of an ultra-thin matrix/analyte layer for analyzing peptides and proteins by Matrix-Assisted Laser Desorption ...

Biologia

Analyzing Large Protein Complexes by Structural Mass Spectrometry

Living cells control and regulate their biological processes through the coordinated action of a large number of proteins that assemble themselves into an array of dynamic, multi-protein complexes1. To gain a mechanistic understanding of the various cellular processes, it is crucial to determine the structure of such protein complexes, and reveal how their structural organization dictates their function. Many aspects of multi-protein complexes are, however, difficult to characterize, due to their heterogeneous nature, asymmetric structure, and dynamics. Therefore, new approaches are required for the study of the tertiary levels of protein organization.
One of the emerging structural biology tools for analyzing macromolecular complexes is mass spectrometry (MS)2-5. This method yields information on the complex protein composition, subunit stoichiometry, and structural topology. The power of MS derives from its high sensitivity and, as a consequence, low sample requirement, which enables examination of protein complexes expressed at endogenous levels. Another advantage is the speed of analysis, which allows monitoring of reactions in real time. Moreover, the technique can simultaneously measure the characteristics of separate populations co-existing in a mixture. 
Here, we describe a detailed protocol for the application of structural MS to the analysis of large protein assemblies. The procedure begins with the preparation of gold-coated capillaries for nanoflow electrospray ionization (nESI). It then continues with sample preparation, emphasizing the buffer conditions which should be compatible with nESI on the one hand, and enable to maintain complexes intact on the other. We then explain, step-by-step, how to optimize the experimental conditions for high mass measurements and acquire MS and tandem MS spectra. Finally, we chart the data processing and analyses that follow. Rather than attempting to characterize every aspect of protein assemblies, this protocol introduces basic MS procedures, enabling the performance of MS and MS/MS experiments on non-covalent complexes. Overall, our goal is to provide researchers unacquainted with the field of structural MS, with knowledge of the principal experimental tools.

Mass spectrometry has proven to be a valuable tool for analyzing large protein complexes. This method enables insights into the composition, stoichiometry and overall architecture of multi-subunit assemblies. Here, we describe, step-by-step, how to perform a structural mass spectrometry analysis, and characterize macromolecular structures.

Analisar grandes complexos de proteínas por espectrometria de massa estruturais

Living cells control and regulate their biological processes through the coordinated action of a large number of proteins that assemble themselves into an ...

T-wave Ion Mobility-mass Spectrometry: Basic Experimental Procedures for Protein Complex Analysis

Ion mobility (IM) is a method that measures the time taken for an ion to travel through a pressurized cell under the influence of a weak electric field. The speed by which the ions traverse the drift region depends on their size: large ions will experience a greater number of collisions with the background inert gas (usually N2) and thus travel more slowly through the IM device than those ions that comprise a smaller cross-section. In general, the time it takes for the ions to migrate though the dense gas phase separates them, according to their collision cross-section (&Omega;). 
Recently, IM spectrometry was coupled with mass spectrometry and a traveling-wave (T-wave) Synapt ion mobility mass spectrometer (IM-MS) was released. Integrating mass spectrometry with ion mobility enables an extra dimension of sample separation and definition, yielding a three-dimensional spectrum (mass to charge, intensity, and drift time). This separation technique allows the spectral overlap to decrease, and enables resolution of heterogeneous complexes with very similar mass, or mass-to-charge ratios, but different drift times. Moreover, the drift time measurements provide an important layer of structural information, as &Omega; is related to the overall shape and topology of the ion. The correlation between the measured drift time values and &Omega; is calculated using a calibration curve generated from calibrant proteins with defined cross-sections1.
The power of the IM-MS approach lies in its ability to define the subunit packing and overall shape of protein assemblies at micromolar concentrations, and near-physiological conditions1. Several recent IM studies of both individual proteins2,3 and non-covalent protein complexes4-9, successfully demonstrated that protein quaternary structure is maintained in the gas phase, and highlighted the potential of this approach in the study of protein assemblies of unknown geometry. Here, we provide a detailed description of IMS-MS analysis of protein complexes using the Synapt (Quadrupole-Ion Mobility-Time-of-Flight) HDMS instrument (Waters Ltd; the only commercial IM-MS instrument currently available)10. We describe the basic optimization steps, the calibration of collision cross-sections, and methods for data processing and interpretation. The final step of the protocol discusses methods for calculating theoretical &Omega; values. Overall, the protocol does not attempt to cover every aspect of IM-MS characterization of protein assemblies; rather, its goal is to introduce the practical aspects of the method to new researchers in the field.

Ion mobility-mass spectrometry is an emerging gas-phase technology that separates ions, based on their collision cross-section and mass. The method provides three-dimensional information on the overall topology and shape of protein complexes. Here, we outline a basic procedure for instrument setting and optimization, calibration of drift times, and data interpretation.

T-wave Ion Mobility Spectrometry massa: Basic Procedimentos para Análise Experimental Protein Complex

Ion mobility (IM) is a method that measures the time taken for an ion to travel through a pressurized cell under the influence of a weak electric field. ...

Quantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry

There is a great need for quantitative assays in measuring proteins. Traditional sandwich immunoassays, largely considered the gold standard in quantitation, are associated with a high cost, long lead time, and are fraught with drawbacks (e.g. heterophilic antibodies, autoantibody interference, 'hook-effect').1 An alternative technique is affinity enrichment of peptides coupled with quantitative mass spectrometry, commonly referred to as SISCAPA (Stable Isotope Standards and Capture by Anti-Peptide Antibodies).2 In this technique, affinity enrichment of peptides with stable isotope dilution and detection by selected/multiple reaction monitoring mass spectrometry (SRM/MRM-MS) provides quantitative measurement of peptides as surrogates for their respective proteins. SRM/MRM-MS is well established for accurate quantitation of small molecules 3, 4 and more recently has been adapted to measure the concentrations of proteins in plasma and cell lysates.5-7 To achieve quantitation of proteins, these larger molecules are digested to component peptides using an enzyme such as trypsin. One or more selected peptides whose sequence is unique to the target protein in that species (i.e. "proteotypic" peptides) are then enriched from the sample using anti-peptide antibodies and measured as quantitative stoichiometric surrogates for protein concentration in the sample. Hence, coupled to stable isotope dilution (SID) methods (i.e. a spiked-in stable isotope labeled peptide standard), SRM/MRM can be used to measure concentrations of proteotypic peptides as surrogates for quantification of proteins in complex biological matrices. The assays have several advantages compared to traditional immunoassays. The reagents are relatively less expensive to generate, the specificity for the analyte is excellent, the assays can be highly multiplexed, enrichment can be performed from neat plasma (no depletion required), and the technique is amenable to a wide array of proteins or modifications of interest.8-13 In this video we demonstrate the basic protocol as adapted to a magnetic bead platform.

Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) couples affinity enrichment of peptides with stable isotope dilution mass spectrometry (MRM-MS) to provide quantitative measurement of peptides as surrogates for their respective proteins. Here we describe the protocol using magnetic particles in a partially automated format.

Quantificação de Proteínas Usando Enriquecimento imunoafinidade Peptide Acoplado com Espectrometria de Massa

There is a great need for quantitative assays in measuring proteins. Traditional sandwich immunoassays, largely considered the gold standard in ...

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry

Pseudomonas syringae pv. tomato strain DC3000 not only causes bacterial speck disease in Solanum lycopersicum but also on Brassica species, as well as on Arabidopsis thaliana, a genetically tractable host plant1,2. The accumulation of reactive oxygen species (ROS) in cotyledons inoculated with DC3000 indicates a role of ROS in modulating necrotic cell death during bacterial speck disease of tomato3. Hydrogen peroxide, a component of ROS, is produced after inoculation of tomato plants with Pseudomonas3. Hydrogen peroxide can be detected using a histochemical stain 3'-3' diaminobenzidine (DAB)4. DAB staining reacts with hydrogen peroxide to produce a brown stain on the leaf tissue4. ROS has a regulatory role of the cellular redox environment, which can change the redox status of certain proteins5. Cysteine is an important amino acid sensitive to redox changes. Under mild oxidation, reversible oxidation of cysteine sulfhydryl groups serves as redox sensors and signal transducers that regulate a variety of physiological processes6,7. Tandem mass tag (TMT) reagents enable concurrent identification and multiplexed quantitation of proteins in different samples using tandem mass spectrometry8,9. The cysteine-reactive TMT (cysTMT) reagents enable selective labeling and relative quantitation of cysteine-containing peptides from up to six biological samples. Each isobaric cysTMT tag has the same nominal parent mass and is composed of a sulfhydryl-reactive group, a MS-neutral spacer arm and an MS/MS reporter10. After labeling, the samples were subject to protease digestion. The cysteine-labeled peptides were enriched using a resin containing anti-TMT antibody. During MS/MS analysis, a series of reporter ions (i.e., 126-131 Da) emerge in the low mass region, providing information on relative quantitation. The workflow is effective for reducing sample complexity, improving dynamic range and studying cysteine modifications. Here we present redox proteomic analysis of the Pst DC3000 treated tomato (Rio Grande) leaves using cysTMT technology. This high-throughput method has the potential to be applied to studying other redox-regulated physiological processes.

Reactive oxygen species level is elevated when cells encounter stress conditions. Here we show the example of 3'-3' diaminobenzidine staining as well as cysTMT labeling and mass spectrometry to profile the redox proteome in Pseudomonas syringae treated tomato leaves.

Profiling Proteome Redox tiol Usando Isótopos Espectrometria de Massa Tagging

Pseudomonas syringae pv. tomato strain DC3000 not only causes bacterial speck disease in Solanum lycopersicum but also on Brassica species, as well as on ...

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Since most cellular processes are mediated by macromolecular assemblies, the systematic identification of protein-protein interactions (PPI) and the identification of the subunit composition of multi-protein complexes can provide insight into gene function and enhance understanding of biological systems1, 2. Physical interactions can be mapped with high confidence vialarge-scale isolation and characterization of endogenous protein complexes under near-physiological conditions based on affinity purification of chromosomally-tagged proteins in combination with mass spectrometry (APMS). This approach has been successfully applied in evolutionarily diverse organisms, including yeast, flies, worms, mammalian cells, and bacteria1-6. In particular, we have generated a carboxy-terminal Sequential Peptide Affinity (SPA) dual tagging system for affinity-purifying native protein complexes from cultured gram-negative Escherichia coli, using genetically-tractable host laboratory strains that are well-suited for genome-wide investigations of the fundamental biology and conserved processes of prokaryotes1, 2, 7. Our SPA-tagging system is analogous to the tandem affinity purification method developed originally for yeast8, 9, and consists of a calmodulin binding peptide (CBP) followed by the cleavage site for the highly specific tobacco etch virus (TEV) protease and three copies of the FLAG epitope (3X FLAG), allowing for two consecutive rounds of affinity enrichment. After cassette amplification, sequence-specific linear PCR products encoding the SPA-tag and a selectable marker are integrated and expressed in frame as carboxy-terminal fusions in a DY330 background that is induced to transiently express a highly efficient heterologous bacteriophage lambda recombination system10. Subsequent dual-step purification using calmodulin and anti-FLAG affinity beads enables the highly selective and efficient recovery of even low abundance protein complexes from large-scale cultures. Tandem mass spectrometry is then used to identify the stably co-purifying proteins with high sensitivity (low nanogram detection limits).
Here, we describe detailed step-by-step procedures we commonly use for systematic protein tagging, purification and mass spectrometry-based analysis of soluble protein complexes from E. coli, which can be scaled up and potentially tailored to other bacterial species, including certain opportunistic pathogens that are amenable to recombineering. The resulting physical interactions can often reveal interesting unexpected components and connections suggesting novel mechanistic links. Integration of the PPI data with alternate molecular association data such as genetic (gene-gene) interactions and genomic-context (GC) predictions can facilitate elucidation of the global molecular organization of multi-protein complexes within biological pathways. The networks generated for E. coli can be used to gain insight into the functional architecture of orthologous gene products in other microbes for which functional annotations are currently lacking.

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Affinity purification of tagged proteins in combination with mass spectrometry (APMS) is a powerful method for the systematic mapping of protein interaction networks and for investigating the mechanistic basis of biological processes. Here, we describe an optimized sequential peptide affinity (SPA) APMS procedure developed for the bacterium Escherichia coli that can be used to isolate and characterize stable multi-protein complexes to near homogeneity even starting from low copy numbers per cell.

Identificação de complexos de proteínas em<em&gt; Escherichia coli</em&gt; Utilizando a purificação por afinidade sequencial Peptide em combinação com espectrometria de massa tandem

Since most cellular processes are mediated by macromolecular assemblies, the systematic identification of protein-protein interactions (PPI) and the ...

A Protocol for the Identification of Protein-protein Interactions Based on 15N Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and Affinity Modulation

Protein-protein interactions are fundamental for many biological processes in the cell. Therefore, their characterization plays an important role in current research and a plethora of methods for their investigation is available1. Protein-protein interactions often are highly dynamic and may depend on subcellular localization, post-translational modifications and the local protein environment2. Therefore, they should be investigated in their natural environment, for which co-immunoprecipitation approaches are the method of choice3. Co-precipitated interaction partners are identified either by immunoblotting in a targeted approach, or by mass spectrometry (LC-MS/MS) in an untargeted way. The latter strategy often is adversely affected by a large number of false positive discoveries, mainly derived from the high sensitivity of modern mass spectrometers that confidently detect traces of unspecifically precipitating proteins. A recent approach to overcome this problem is based on the idea that reduced amounts of specific interaction partners will co-precipitate with a given target protein whose cellular concentration is reduced by RNAi, while the amounts of unspecifically precipitating proteins should be unaffected. This approach, termed QUICK for QUantitative Immunoprecipitation Combined with Knockdown4, employs Stable Isotope Labeling of Amino acids in Cell culture (SILAC)5 and MS to quantify the amounts of proteins immunoprecipitated from wild-type and knock-down strains. Proteins found in a 1:1 ratio can be considered as contaminants, those enriched in precipitates from the wild type as specific interaction partners of the target protein. Although innovative, QUICK bears some limitations: first, SILAC is cost-intensive and limited to organisms that ideally are auxotrophic for arginine and/or lysine. Moreover, when heavy arginine is fed, arginine-to-proline interconversion results in additional mass shifts for each proline in a peptide and slightly dilutes heavy with light arginine, which makes quantification more tedious and less accurate5,6. Second, QUICK requires that antibodies are titrated such that they do not become saturated with target protein in extracts from knock-down mutants.
Here we introduce a modified QUICK protocol which overcomes the abovementioned limitations of QUICK by replacing SILAC for 15N metabolic labeling and by replacing RNAi-mediated knock-down for affinity modulation of protein-protein interactions. We demonstrate the applicability of this protocol using the unicellular green alga Chlamydomonas reinhardtii as model organism and the chloroplast HSP70B chaperone as target protein7 (Figure 1). HSP70s are known to interact with specific co-chaperones and substrates only in the ADP state8. We exploit this property as a means to verify the specific interaction of HSP70B with its nucleotide exchange factor CGE19.

A Protocol for the Identification of Protein-protein Interactions Based on 15N Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and Affinity Modulation

We present a variation of the QUICK (QUantitative Immunoprecipitation Combined with Knockdown) approach that was introduced previously to distinguish between true and false protein-protein interactions. Our approach is based on 15N metabolic labeling, the modulation of affinities of protein-protein interactions by the presence/absence of ATP, immunoprecipitation, and quantitative mass spectrometry.

Um protocolo para a identificação de interações proteína-proteína Baseado<sup&gt; 15</sup&gt; Etiquetagem N Metabólica, imunoprecipitação, Quantitativa Espectrometria de Massa e Affinity Modulação

Protein-protein interactions are fundamental for many biological processes in the cell. Therefore, their characterization plays an important role in ...

Coupled Assays for Monitoring Protein Refolding in Saccharomyces cerevisiae

Proteostasis, defined as the combined processes of protein folding/biogenesis, refolding/repair, and degradation, is a delicate cellular balance that must be maintained to avoid deleterious consequences 1. External or internal factors that disrupt this balance can lead to protein aggregation, toxicity and cell death. In humans this is a major contributing factor to the symptoms associated with neurodegenerative disorders such as Huntington's, Parkinson's, and Alzheimer's diseases 10. It is therefore essential that the proteins involved in maintenance of proteostasis be identified in order to develop treatments for these debilitating diseases. This article describes techniques for monitoring in vivo protein folding at near-real time resolution using the model protein firefly luciferase fused to green fluorescent protein (FFL-GFP). FFL-GFP is a unique model chimeric protein as the FFL moiety is extremely sensitive to stress-induced misfolding and aggregation, which inactivates the enzyme 12. Luciferase activity is monitored using an enzymatic assay, and the GFP moiety provides a method of visualizing soluble or aggregated FFL using automated microscopy. These coupled methods incorporate two parallel and technically independent approaches to analyze both refolding and functional reactivation of an enzyme after stress. Activity recovery can be directly correlated with kinetics of disaggregation and re-solubilization to better understand how protein quality control factors such as protein chaperones collaborate to perform these functions. In addition, gene deletions or mutations can be used to test contributions of specific proteins or protein subunits to this process. In this article we examine the contributions of the protein disaggregase Hsp104 13, known to partner with the Hsp40/70/nucleotide exchange factor (NEF) refolding system 5, to protein refolding to validate this approach.

Coupled Assays for Monitoring Protein Refolding in Saccharomyces cerevisiae

This article describes the use of a firefly luciferase-GFP fusion protein to investigate in vivo protein folding in Saccharomyces cerevisiae. Using this reagent, refolding of a model heat-denatured protein can be monitored simultaneously by fluorescence microscopy and an enzymatic assay to probe the roles of proteostasis network components in protein quality control.

Ensaios para Monitoramento juntamente redobramento de proteínas em<em&gt; Saccharomyces cerevisiae</em

Proteostasis, defined as the combined processes of protein folding/biogenesis, refolding/repair, and degradation, is a delicate cellular balance that must ...

Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis

The extracellular matrix (ECM) is a complex meshwork of cross-linked proteins that provides biophysical and biochemical cues that are major regulators of cell proliferation, survival, migration, etc. The ECM plays important roles in development and in diverse pathologies including cardio-vascular and musculo-skeletal diseases, fibrosis, and cancer. Thus, characterizing the composition of ECMs of normal and diseased tissues could lead to the identification of novel prognostic and diagnostic biomarkers and potential novel therapeutic targets. However, the very nature of ECM proteins (large in size, cross-linked and covalently bound, heavily glycosylated) has rendered biochemical analyses of ECMs challenging. To overcome this challenge, we developed a method to enrich ECMs from fresh or frozen tissues and tumors that takes advantage of the insolubility of ECM proteins. We describe here in detail the decellularization procedure that consists of sequential incubations in buffers of different pH and salt and detergent concentrations and that results in 1) the extraction of intracellular (cytosolic, nuclear, membrane and cytoskeletal) proteins and 2) the enrichment of ECM proteins. We then describe how to deglycosylate and digest ECM-enriched protein preparations into peptides for subsequent analysis by mass spectrometry.

This protocol describes a procedure for enriching ECM proteins from tissues or tumors and deglycosylating and digesting the ECM-enriched preparations into peptides to analyze their protein composition by mass spectrometry.

Enriquecimento de Proteínas da Matriz Extracelular a partir de tecidos e digestão em péptidos para Análise de Espectrometria de Massa

The extracellular matrix (ECM) is a complex meshwork of cross-linked proteins that provides biophysical and biochemical cues that are major regulators of ...

Combining Chemical Cross-linking and Mass Spectrometry of Intact Protein Complexes to Study the Architecture of Multi-subunit Protein Assemblies

Proteins interact with their ligands to form active and dynamic assemblies which carry out various cellular functions. Elucidating these interactions is therefore fundamental for the understanding of cellular processes. However, many protein complexes are dynamic assemblies and are not accessible by conventional structural techniques. Mass spectrometry contributes to the structural investigation of these assemblies, and particularly the combination of various mass spectrometric techniques delivers valuable insights into their structural arrangement.
In this article, we describe the application and combination of two complementary mass spectrometric techniques, namely chemical cross-linking coupled with mass spectrometry and native mass spectrometry. Chemical cross-linking involves the covalent linkage of amino acids in close proximity by using chemical reagents. After digestion with proteases, cross-linked di-peptides are identified by mass spectrometry and protein interactions sites are uncovered. Native mass spectrometry on the other hand is the analysis of intact protein assemblies in the gas phase of a mass spectrometer. It reveals protein stoichiometries as well as protein and ligand interactions. Both techniques therefore deliver complementary information on the structure of protein-ligand assemblies and their combination proved powerful in previous studies.

The architecture of protein complexes is essential for their function. Combining various mass spectrometric techniques proved powerful to study their assembly. We provide protocols for chemical cross-linking and native mass spectrometry and show how these complementary techniques help to elucidate the architecture of multi-subunit protein assemblies.

Combinando reticulação química e espectrometria de massa de complexos de proteínas intactas para estudar a arquitetura de montagens de proteínas com multi- subunidades

Proteins interact with their ligands to form active and dynamic assemblies which carry out various cellular functions. Elucidating these interactions is ...